Hepatic insulin synthesis increases in rat models of diabetes mellitus type 1 and 2 differently DOI Creative Commons

М. Т. Абидов,

Ksenia Sokolova, И. Г. Данилова

et al.

PLoS ONE, Journal Year: 2023, Volume and Issue: 18(11), P. e0294432 - e0294432

Published: Nov. 29, 2023

Insulin-positive (+) cells (IPCs), detected in multiple organs, are of great interest as a probable alternative to ameliorate pancreatic beta-cells dysfunction and insulin deficiency diabetes. Liver is potential source IPCs due it common embryological origin with pancreas. We previously demonstrated the presence liver healthy diabetic rats, but detailed description analysis factors, which potentially can induced ectopic hepatic expression type 1 (T1D) 2 diabetes (T2D), were not performed. In present study we evaluate mass rat models T1D T2D discuss may stimulate generation: glycaemia, organ injury, involving stem/progenitor cell compartment, transcription factors inflammation. Quantity was up by 1.7-fold rats 10-fold compared non-diabetic (ND) rats. concluded that gene activated combined action number inflammation playing decision role.

Language: Английский

Estradiol contributes to sex differences in resilience to sepsis-induced metabolic dysregulation and dysfunction in the heart via GPER-1-mediated PPARδ/NLRP3 signaling DOI
Joseph Adu‐Amankwaah, Adebayo Oluwafemi Adekunle, Ziqing Tang

et al.

Metabolism, Journal Year: 2024, Volume and Issue: 156, P. 155934 - 155934

Published: May 16, 2024

Language: Английский

Citations

12

Revolution in sepsis: a symptoms-based to a systems-based approach? DOI Creative Commons
Geoffrey P. Dobson, Hayley L. Letson, Jodie L. Morris

et al.

Journal of Biomedical Science, Journal Year: 2024, Volume and Issue: 31(1)

Published: May 30, 2024

Abstract Severe infection and sepsis are medical emergencies. High morbidity mortality linked to CNS dysfunction, excessive inflammation, immune compromise, coagulopathy multiple organ dysfunction. Males appear have a higher risk of than females. Currently, there few or no effective drug therapies protect the brain, maintain blood brain barrier, resolve inflammation reduce secondary injury in other vital organs. We propose major reason for lack progress is consequence treat-as-you-go, single-nodal target approach, rather more integrated, systems-based approach. A new revolution required better understand how body responds an infection, identify markers detect its progression discover system-acting drugs treat it. In this review, we present brief history followed by pathophysiology from systems’ perspective future opportunities. argue that targeting body’s early immune-driven CNS-response may improve patient outcomes. If barrage PAMPs DAMPs can be reduced early, CNS-organ circuits (or axes) will preserved reduced. been developing systems-based, small-volume, fluid therapy comprising adenosine, lidocaine magnesium (ALM) endotoxemia. Our studies indicate ALM shifts sympathetic parasympathetic dominance, maintains cardiovascular-endothelial glycocalyx coupling, reduces corrects coagulopathy, tissue O 2 supply. Future research investigate potential translation humans.

Language: Английский

Citations

7

HDL-based therapeutics: A promising frontier in combating viral and bacterial infections DOI Creative Commons
Alankrita Rani,

Julia T. Stadler,

Gunther Marsche

et al.

Pharmacology & Therapeutics, Journal Year: 2024, Volume and Issue: 260, P. 108684 - 108684

Published: July 2, 2024

Language: Английский

Citations

6

Immunometabolic reprogramming of macrophages with inhalable CRISPR/Cas9 nanotherapeutics for acute lung injury intervention DOI

Wanling Huang,

Gaohong Fu,

Yangeng Wang

et al.

Acta Biomaterialia, Journal Year: 2024, Volume and Issue: 181, P. 308 - 316

Published: April 1, 2024

Language: Английский

Citations

5

Cycloastragenol Reduces Inflammation in CLP-induced Septic Mice by Suppressing TLR4 Signaling Pathways DOI
Guang‐Hong Chen, Weihong Wang, Baoyi Guan

et al.

Phytomedicine, Journal Year: 2025, Volume and Issue: 142, P. 156645 - 156645

Published: March 13, 2025

Language: Английский

Citations

0

Advances in sepsis research: Insights into signaling pathways, organ failure, and emerging intervention strategies DOI Creative Commons
Yehua Li, Siying Ren,

Shenao Zhou

et al.

Experimental and Molecular Pathology, Journal Year: 2025, Volume and Issue: 142, P. 104963 - 104963

Published: March 27, 2025

Language: Английский

Citations

0

Integrated Metabolomics and Lipidomics Analysis Reveals the Mechanism Behind the Action of Chiglitazar on the Protection Against Sepsis-Induced Acute Lung Injury DOI Creative Commons

Liu-Liu Lu,

Yubin Cao,

Zhen-Chen Lu

et al.

Metabolites, Journal Year: 2025, Volume and Issue: 15(5), P. 290 - 290

Published: April 25, 2025

Background: Sepsis-induced acute lung injury (SALI) is a critical clinical challenge with high mortality. Metabolic dysregulation drives SALI pathogenesis, disrupting function and energy metabolism. Despite proven benefits, metabolic restoration underused in sepsis. This study explores chiglitazar’s role balancing metabolism to protect against SALI. Methods: The protective effects of chiglitazar CLP rats were demonstrated by the survival curve, histological analysis, immunohistochemical analysis tissue. Metabolomic lipidomic analyses tissue samples using gas chromatography–mass spectrometry (GC-MS) liquid (LC-MS) performed evaluate shifts induced surgery pretreatment. mRNA protein levels underlying targets directing nicotinamide adenine dinucleotide (NAD+) triglyceride synthesis analyzed qPCR Western blotting. To validate mechanism which protected SALI, SIRT1 inhibitor EX-527 was applied human normal epithelial (BEAS-2B) cells another batch observe its reverse effect action. Results: Chiglitazar pretreatment significantly restored NAD+ improved dysregulated lipid enhancing triglycerides (TGs) suppressing accumulated fatty acids (FAs). modulation mediated associated upregulations SIRT1/PGC-1α/PPARα/GPAT3 axis. Co-treatment LPS-stimulated BEAS-2B inhibited on aforementioned signaling pathways worsened injury, respectively. Conclusions: alleviates restoring TG synthesis, highlighting as promising therapeutic strategy management

Language: Английский

Citations

0

Low, Intermediate, and High Glutamine Levels Are Progressively Associated with Increased Lymphopenia, a Diminished Inflammatory Response, and Higher Mortality in Internal Medicine Patients with Sepsis DOI Open Access
Filippo Mearelli, Alessio Nunnari,

Federica Chitti

et al.

Journal of Clinical Medicine, Journal Year: 2025, Volume and Issue: 14(10), P. 3313 - 3313

Published: May 9, 2025

Background: The pathophysiological mechanisms underlying altered plasma glutamine concentrations in sepsis remain poorly understood. Identifying clinical, immunological, and metabolic correlates of fluctuations is crucial to advancing precision medicine, developing targeted therapies, improving survival outcomes septic patients. Methods: We enrolled 469 patients with assessed inflammatory markers—including body temperature, white blood cell count, C-reactive protein levels—upon admission the internal medicine unit. Lymphocyte count glutamine, glutamic acid, 5-oxoproline, phenylalanine, tyrosine, leucine were measured using gas chromatography–mass spectrometry. Patients stratified into three groups based on levels. Mortality was recorded at 30 days 6 months. Results: Low, intermediate, high levels observed 46% (n = 217), 47% 218), 7% 34) patients, respectively. hyperglutaminemia exhibited significantly lower lymphocyte counts, levels, acid-to-5-oxoproline ratio (a surrogate marker glutathione availability), along elevated phenylalanine tyrosine-to-phenylalanine (all p < 0.01). Metabolic disruption mortality increased progressively across level groups. Kaplan–Meier analysis demonstrated higher both (log-rank 0.03) months 0.05). Conclusions: At baseline, increasing are associated deeper lymphopenia, more pronounced derangement, short- long-term sepsis.

Language: Английский

Citations

0

P2Y2 purinergic receptor gene deletion protects mice from bacterial endotoxin and sepsis-associated liver injury and mortality DOI

Athis Arunachalam,

Sanju S. Samuel,

Arunmani Mani

et al.

AJP Gastrointestinal and Liver Physiology, Journal Year: 2023, Volume and Issue: 325(5), P. G471 - G491

Published: Sept. 12, 2023

The liver plays a significant role in regulating wide range of metabolic, homeostatic, and host-defense functions. However, the impact injury on host's ability to control bacteremia morbidity sepsis is not well understood. Leukocyte recruitment activation lead cytokine chemokine release, which, turn, trigger hepatocellular elevate nucleotide levels extracellular milieu. P2Y2 purinergic receptors, G protein-coupled activated by ATP/UTP, are expressed at cell surface hepatocytes nonparenchymal cells. We sought determine whether receptor function necessary for maladaptive host response bacterial infection endotoxin-mediated inflammatory mortality mice. report that knockout mice (P2Y2

Language: Английский

Citations

8

Construction and validation of a mitochondria-associated genes prognostic signature and immune microenvironment characteristic of sepsis DOI
Qi Shu,

Yuanlin Du,

Han She

et al.

International Immunopharmacology, Journal Year: 2023, Volume and Issue: 126, P. 111275 - 111275

Published: Nov. 22, 2023

Language: Английский

Citations

7